Bitter Pill To Swallow: Can The US Market Bear The Cost Of Sovaldi?

Sovaldi, the new drug to treat and cure Hepatitis C has certainly caused quite an uproar in the US since its FDA approval in December of 2013.  At $1,000 per pill, the manufacturer, Gilead, has plenty of people and payers to answer to in order to justify this enormous cost, say industry experts and watchdogs.